Research graph
References from Use of bevacizumab in elderly patients with metastatic colorectal cancer: Review. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2010
10.3322/caac.20073 · 2010 · External reference
Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s
10.1016/j.ejca.2007.12.015 · 2008 · External reference
Prevalence of patients with colorectal cancer requiring follow-up or active treatment
10.1016/j.ejca.2009.01.012 · 2009 · External reference
Epidemiology and prognosis of synchronous colorectal cancers
10.1002/bjs.6382 · 2008 · External reference
Management and survival of colorectal cancer in the elderly in population-based studies
10.1016/j.ejca.2007.08.008 · 2007 · External reference
Randomized strategical trial of chemotherapy in metastatic colorectal cancer (FFCD 2000–05): preliminary results
10.1200/jco.2007.25.18_suppl.4069 · 2007 · External reference
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
10.1016/s0140-6736(07)61086-1 · 2007 · External reference
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial
10.1016/s0140-6736(07)61087-3 · 2007 · External reference
Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials
10.1093/annonc/mdh344 · 2004 · External reference
Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administrated bimonthly in elderly patients with colorectal cancer
10.1200/jco.2006.06.9039 · 2006 · External reference
10.1016/s1040-8428(08)70044-1
10.1016/s1040-8428(08)70044-1 · External reference
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
10.1038/sj.bjc.6601310 · 2003 · External reference
Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a phase II study
10.1007/s00280-008-0681-2 · 2008 · External reference
Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors
10.1177/107327480701400312 · 2007 · External reference
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy
10.1126/science.1104819 · 2005 · External reference
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
10.1056/nejmoa032691 · 2004 · External reference
Unresolved reference
External reference
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study
10.1200/jco.2007.14.9930 · 2008 · External reference
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
10.1200/jco.2006.09.6305 · 2007 · External reference
Addition of bevacizumab to bolus flurouracil and leucovorin in first-line metastatic colorectal cancer: results of randomized phase II trial
10.1200/jco.2005.05.112 · 2005 · External reference
Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials
10.1200/jco.2008.17.7931 · 2009 · External reference
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer
10.1016/s0140-6736(00)02528-9 · 2000 · External reference
Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies
10.1007/s00432-009-0712-3 · 2010 · External reference
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
10.1093/annonc/mdp233 · 2009 · External reference
Safety and efficacy of bevacizumab (BEV) and chemotherapy in elderly patients with metastatic colorectal cancer: results from the BEAT observational cohort study
10.1016/s1359-6349(09)71183-8 · 2009 · External reference
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study
10.1634/theoncologist.2009-0071 · 2009 · External reference
10.1200/jco.2008.26.15_suppl.4026
10.1200/jco.2008.26.15_suppl.4026 · External reference
Unresolved reference
External reference
A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer
10.1016/j.critrevonc.2008.10.012 · 2009 · External reference
Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
10.1038/sj.bjc.6605663 · 2010 · External reference
Phase II study of bevacizumab in combination with capecitabine as first line treatment in elderly patients with metastatic colorectal cancer
10.1200/jco.2009.27.15_suppl.e15074 · 2009 · External reference
Unresolved reference
External reference
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidynes in first-line treatment of metastatic colorectal cancer: results from the BICC-C study
10.1200/jco.2007.11.3357 · 2007 · External reference
Initial safety report of NSABP C-08: a randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer
10.1200/jco.2009.21.9220 · 2009 · External reference
Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials
10.3109/02841860903524396 · 2010 · External reference
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
10.1093/jnci/djm086 · 2007 · External reference
Bevacizumab related adverse events among various age groups of elderly patients with advanced colorectal cancer
10.1200/jco.2007.25.18_suppl.14546 · 2007 · External reference
Hemostatic complications of angiogenesis inhibitors in cancer patients
10.1002/ajh.21277 · 2008 · External reference
FOLFOX in patients aged between 76 and 80years with metastatic colorectal cancer
10.1002/cncr.23091 · 2007 · External reference
Age and adjuvant chemotherapy use after surgery for stage III colon cancer
10.1093/jnci/93.11.850 · 2001 · External reference
